Completed PHASE4 INTERVENTIONAL 2-arm NCT01922479

Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure (PRACTICEASIAHF)

Pilot RAndomized Controlled Trial of FerrIC CarboxymaltosE in ASIAns With Heart Failure (the PRACTICE-ASIA-HF) Study

Sponsor: National University Heart Centre, Singapore

Conditions Anemia Heart Failure Iron Deficiency

Interventions Ferric Carboxymaltose Placebo

Updated 6 times since 2017 Last updated: Apr 11, 2017 Started: Sep 30, 2013 Primary completion: Sep 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Anemia and Heart Failure, this trial is completed. The trial is conducted by National University Heart Centre, Singapore and has accumulated 6 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
May 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Unknown Status PHASE4

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National University Heart Centre, Singapore
National University Hospital, Singapore
Tan Tock Seng Hospital

Data source: National University Hospital, Singapore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Singapore, Singapore